
CTI BioPharma Corp. CTIC
Quarterly report 2023-Q1
added 05-15-2023
CTI BioPharma Corp. PEG Ratio 2011-2026 | CTIC
Annual PEG Ratio CTI BioPharma Corp.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.94 | 0.952 | 0.621 | 0.0536 | -0.0385 | -0.0812 | -0.0349 | 0.936 | 0.0684 | -0.113 | -0.0189 | -0.0649 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.94 | -0.113 | 0.602 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M | ||
|
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | ||
|
Autolus Therapeutics plc
AUTL
|
0.0906 | $ 1.37 | -8.67 % | $ 350 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | ||
|
Alterity Therapeutics Limited
ATHE
|
-0.0509 | $ 3.43 | -2.69 % | $ 8.25 B | ||
|
Biogen
BIIB
|
-1.57 | $ 177.93 | -4.15 % | $ 25.9 B | ||
|
Arrowhead Pharmaceuticals
ARWR
|
-141 | $ 65.89 | -0.06 % | $ 8.81 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | ||
|
Akero Therapeutics
AKRO
|
-0.964 | - | - | $ 3.67 B | ||
|
AVROBIO
AVRO
|
0.068 | - | 1083.1 % | $ 745 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M | ||
|
AstraZeneca PLC
AZN
|
-369 | $ 94.4 | 0.82 % | $ 96.9 B | ||
|
BeiGene, Ltd.
BGNE
|
9.68 | - | 0.49 % | $ 251 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
0.000006 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
0.863 | - | -7.31 % | $ 87 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
-0.767 | $ 214.55 | 2.77 % | $ 5 B | ||
|
Codiak BioSciences
CDAK
|
0.0282 | - | -55.98 % | $ 2.15 M | ||
|
ARCA biopharma
ABIO
|
-0.0372 | - | 1052.0 % | $ 415 M | ||
|
Bristol-Myers Squibb Company
BMY
|
-1.27 | $ 55.84 | 0.13 % | $ 113 B | ||
|
Acasti Pharma
ACST
|
-0.0483 | - | 4.01 % | $ 150 M | ||
|
Caladrius Biosciences
CLBS
|
-0.00197 | - | -16.75 % | $ 25.8 M | ||
|
BioLineRx Ltd.
BLRX
|
1.32 | $ 2.86 | - | $ 908 M | ||
|
Clearside Biomedical
CLSD
|
-0.00335 | - | - | $ 25.3 M | ||
|
Chimerix
CMRX
|
-0.042 | - | - | $ 756 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-0.00126 | - | -15.15 % | $ 60.3 M | ||
|
BioNTech SE
BNTX
|
-12.8 | $ 106.88 | 4.6 % | $ 27.2 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
6.6 | $ 4.18 | -1.65 % | $ 9.1 B | ||
|
AIkido Pharma
AIKI
|
-0.000777 | - | 1.93 % | $ 17.4 M | ||
|
Catalyst Biosciences
CBIO
|
0.00243 | $ 11.09 | 1.0 % | $ 730 M | ||
|
Albireo Pharma
ALBO
|
-2.41 | - | -0.23 % | $ 916 M | ||
|
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
0.0443 | - | 2.71 % | $ 14 M | ||
|
Alpine Immune Sciences
ALPN
|
4.18 | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.0783 | - | - | $ 7.46 M | ||
|
Coherus BioSciences
CHRS
|
0.0108 | $ 1.69 | 2.12 % | $ 159 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.000293 | - | -11.43 % | $ 502 K | ||
|
Amphastar Pharmaceuticals
AMPH
|
0.0954 | $ 28.99 | -1.39 % | $ 1.4 B | ||
|
Celldex Therapeutics
CLDX
|
-0.000001 | $ 25.71 | 0.16 % | $ 1.66 M | ||
|
Cellectis S.A.
CLLS
|
0.00224 | $ 4.24 | -0.47 % | $ 116 M | ||
|
Acorda Therapeutics
ACOR
|
-0.000047 | - | -24.86 % | $ 820 K | ||
|
Applied Molecular Transport
AMTI
|
0.133 | - | - | $ 10.1 M | ||
|
Brickell Biotech
BBI
|
-0.00369 | - | -5.38 % | $ 6.06 M | ||
|
Burford Capital Limited
BUR
|
-0.568 | $ 9.57 | -0.78 % | $ 1.55 B |